(Q33521026)

27 July 2017

title

Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema (English)

1 reference

27 July 2017

main subject

diabetic macular edema

1 reference

1

Emily Y Chew

1 reference

27 July 2017

6

Michael Ip

1 reference

27 July 2017

Jonghyeon Kim

2

1 reference

27 July 2017

Hanna R Coleman

3

1 reference

27 July 2017

Lloyd Paul Aiello

4

1 reference

27 July 2017

Gary Fish

5

1 reference

27 July 2017

Julia A Haller

7

1 reference

27 July 2017

Maria Figueroa

8

1 reference

27 July 2017

Daniel Martin

9

1 reference

27 July 2017

David Callanan

10

1 reference

27 July 2017

Robert Avery

11

1 reference

27 July 2017

Keri Hammel

12

1 reference

27 July 2017

Darby J S Thompson

13

1 reference

27 July 2017

Frederick L Ferris

14

1 reference

27 July 2017

publication date

1 March 2010

1 reference

27 July 2017

number of pages

9

1 reference

inferred from page(s)

published in

Retina

1 reference

27 July 2017

volume

30

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

459-467

1 reference

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

The prevalence of diabetic retinopathy among adults in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Intravitreal triamcinolone for refractory diabetic macular edema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Laser treatment of retinal diseases by subthreshold laser effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Decreasing retinal photocoagulation damage: principles and techniques

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Progressive Enlargement of Laser Scars Following Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Causes and prevalence of visual impairment among adults in the United States

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025102

New visual acuity charts for clinical research

31 October 2018

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature

1 reference

12 December 2020

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

10.1097/IAE.0B013E3181BCF1A0

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference